{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T23:15:27Z","timestamp":1792278927568,"version":"4.4.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.cgh.2013.01.008","type":"journal-article","created":{"date-parts":[[2013,1,29]],"date-time":"2013-01-29T23:48:05Z","timestamp":1359503285000},"page":"802-807.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":135,"title":["Efficacy of Bismuth-Containing Quadruple Therapies for Clarithromycin-, Metronidazole-, and Fluoroquinolone-Resistant Helicobacter pylori Infections in a Prospective Study"],"prefix":"10.1016","volume":"11","author":[{"given":"Xiao","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinjuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shudong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2013.01.008_bib1","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/gut.2009.192757","article-title":"Helicobacter pylori treatment in the era of increasing antibiotic resistance","volume":"59","author":"Graham","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2013.01.008_bib2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/MOG.0b013e32834bb818","article-title":"Treatment of Helicobacter pylori","volume":"27","author":"Selgrad","year":"2011","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.cgh.2013.01.008_bib3","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/j.1440-1746.2009.05982.x","article-title":"Second Asia-pacific consensus guidelines for Helicobacter pylori infection","volume":"24","author":"Fock","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2013.01.008_bib4","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","article-title":"Management of Helicobacter pylori infection\u2014the Maastricht IV\/Florence consensus report","volume":"61","author":"Malfertheiner","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2013.01.008_bib5","first-page":"1048","article-title":"Double-blind short-term trial of furazolidone in peptic ulcer","volume":"1","author":"Zheng","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2013.01.008_bib6","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1440-1746.1992.tb01034.x","article-title":"Treatment of peptic ulcer disease with furazolidone","volume":"7","author":"Zheng","year":"1992","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2013.01.008_bib7","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1523-5378.2011.00890.x","article-title":"Key points for designing and reporting Helicobacter pylori therapeutic trials: a personal view","volume":"16","author":"Calvet","year":"2011","journal-title":"Helicobacter"},{"key":"10.1016\/j.cgh.2013.01.008_bib8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cgh.2008.10.024","article-title":"Efficient identification and evaluation of effective Helicobacter pylori therapies","volume":"7","author":"Graham","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2013.01.008_bib9","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0016-5085(00)70003-5","article-title":"Therapy of Helicobacter pylori: current status and issues","volume":"118","author":"Graham","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2013.01.008_bib10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1523-5378.2011.00891.x","article-title":"Helicobacter pylori therapy demystified","volume":"16","author":"Graham","year":"2011","journal-title":"Helicobacter"},{"key":"10.1016\/j.cgh.2013.01.008_bib11","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1099\/jmm.0.46316-0","article-title":"Helicobacter pylori isolated from patients who later failed H. pylori eradication triple therapy readily develop resistance to clarithromycin","volume":"55","author":"Kobayashi","year":"2006","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.cgh.2013.01.008_bib12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1542-3565(03)00131-9","article-title":"Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori","volume":"1","author":"Romano","year":"2003","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2013.01.008_bib13","doi-asserted-by":"crossref","first-page":"5118","DOI":"10.3748\/wjg.v16.i40.5118","article-title":"Resistance of Helicobacter pylori to antibiotics from 2000 to 2009 in Shanghai","volume":"16","author":"Sun","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2013.01.008_bib14","doi-asserted-by":"crossref","first-page":"7361","DOI":"10.3748\/wjg.14.7361","article-title":"Adverse events with bismuth salts for Helicobacter pylori eradication: systematic review and meta-analysis","volume":"14","author":"Ford","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2013.01.008_bib15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1523-5378.2000.00027.x","article-title":"Double-blind comparison of absorbable colloidal bismuth subcitrate and nonabsorbable bismuth subnitrate in the eradication of Helicobacter pylori and the relief of nonulcer dyspepsia","volume":"5","author":"Whitehead","year":"2000","journal-title":"Helicobacter"},{"key":"10.1016\/j.cgh.2013.01.008_bib16","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1523-5378.2012.00962.x","article-title":"Greater than 95% success with 14-day bismuth quadruple anti- Helicobacter pylori therapy: a pilot Study in US Hispanics","volume":"17","author":"Salazar","year":"2012","journal-title":"Helicobacter"},{"key":"10.1016\/j.cgh.2013.01.008_bib17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/ije\/31.1.128","article-title":"Sources of variation of Helicobacter pylori treatment success in adults worldwide: a meta-analysis","volume":"31","author":"Fischbach","year":"2002","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.cgh.2013.01.008_bib18","first-page":"347","article-title":"Rescue therapy for treatment failure of Helicobacter pylori infection","volume":"7","author":"Lu","year":"2002","journal-title":"Chin J Gastroenterol"},{"key":"10.1016\/j.cgh.2013.01.008_bib19","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3748\/wjg.15.860","article-title":"Furazolidone, amoxicillin, bismuth and rabeprazole quadruple rescue therapy for the eradication of Helicobacter pylori","volume":"15","author":"Cheng","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2013.01.008_bib20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3109\/00365528909091336","article-title":"Adverse reactions to furazolidone and other drugs","volume":"169","author":"Altamirano","year":"1989","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1016\/j.cgh.2013.01.008_bib21","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1046\/j.1440-1746.2003.03058.x","article-title":"Effect of different doses of furazolidone with amoxicillin and omeprazole on eradication of Helicobacter pylori","volume":"18","author":"Roghani","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2013.01.008_bib22","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/MD.0b013e31821c9d1c","article-title":"Helicobacter pylori infection: a randomized, controlled study comparing 2 rescue therapies after failure of standard triple therapies","volume":"90","author":"Wu","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cgh.2013.01.008_bib23","first-page":"832","article-title":"[Management of Helicobacter pylori infection-the IV Chinese consensus report]","volume":"51","year":"2012","journal-title":"Chin J Intern Med"},{"key":"10.1016\/j.cgh.2013.01.008_bib24","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000048865","article-title":"Second-line Helicobacter pylori eradication with a furazolidone-based regimen in patients who have failed a metronidazole-based regimen","volume":"64","author":"Sotoudehmanesh","year":"2001","journal-title":"Digestion"},{"key":"10.1016\/j.cgh.2013.01.008_bib25","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1046\/j.1365-2036.2001.01122.x","article-title":"One-week regimens containing ranitidine bismuth citrate, furazolidone and either amoxicillin or tetracycline effectively eradicate Helicobacter pylori: a multicenter, randomized, double-blind study","volume":"15","author":"Lu","year":"2001","journal-title":"Aliment Oharmacol Ther"},{"key":"10.1016\/j.cgh.2013.01.008_bib26","first-page":"P127","article-title":"Eradication of Helicobacter pylori in duodenal ulcer disease tetracycline and furazolidone vs. metronidazole and amoxicillin in omeprazole based triple therapy","volume":"8","author":"Mansour-Ghanaei","year":"2002","journal-title":"Med Sci Monit"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154235651300116X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154235651300116X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:11:11Z","timestamp":1761541871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154235651300116X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S154235651300116X"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2013.01.008","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Bismuth-Containing Quadruple Therapies for Clarithromycin-, Metronidazole-, and Fluoroquinolone-Resistant Helicobacter pylori Infections in a Prospective Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2013.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2013.03.050","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 AGA Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}